β 2 ‐Microglobulin Amyloidosis: An Overview
1993; Wiley; Volume: 6; Issue: 2 Linguagem: Inglês
10.1111/j.1525-139x.1993.tb00274.x
ISSN1525-139X
AutoresJosep M. Campistol, Martha Skinner,
Tópico(s)Chronic Myeloid Leukemia Treatments
ResumoSeminars in DialysisVolume 6, Issue 2 p. 117-126 β2-Microglobulin Amyloidosis: An Overview Josep M. Campistol, Josep M. Campistol From the Arthritis Center, Boston University School of Medicine, Boston, MassachusettsSearch for more papers by this authorMartha Skinner, Corresponding Author Martha Skinner From the Arthritis Center, Boston University School of Medicine, Boston, MassachusettsAddress correspondence to: Martha Skinner, MD, Arthritis Center (K-5), Boston University School of Medicine, 71 East Concord Street, Boston, MA 02118.Search for more papers by this author Josep M. Campistol, Josep M. Campistol From the Arthritis Center, Boston University School of Medicine, Boston, MassachusettsSearch for more papers by this authorMartha Skinner, Corresponding Author Martha Skinner From the Arthritis Center, Boston University School of Medicine, Boston, MassachusettsAddress correspondence to: Martha Skinner, MD, Arthritis Center (K-5), Boston University School of Medicine, 71 East Concord Street, Boston, MA 02118.Search for more papers by this author First published: March 1993 https://doi.org/10.1111/j.1525-139X.1993.tb00274.xCitations: 10AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Cohen AS, Calkins E: Electron microscopic observations on a fibrous component in amyloid of diverse origins. Nature 183: 1202–1203, 1959. 10.1038/1831202a0 CASPubMedWeb of Science®Google Scholar 2 Cohen AS: Amyloidosis. N Engl J Med 277: 522–530, 574–583, 1967. 10.1056/NEJM196709072771006 CASPubMedWeb of Science®Google Scholar 3 Bonar LC, Cohen AS, Skinner MM: Characterization of the amyloid fibril as a cross-β protein. Proc Exp Biol Med 131: 1373–1375, 1969. 10.3181/00379727-131-34110 CASPubMedWeb of Science®Google Scholar 4 Husby G, Araki S, Benditt EP, Benson MD, Cohen AS, Frangione B, Glenner G, Natvig JB, Westermark P: The 1990 guidelines for nomenclature and classification of amyloid and amyloidosis, in Amyloid and Amyloidosis 1990, VIth International Symposium on Amyloidosis, JB Natvig, O Forre, G Husby, A Husbekk, B Skogen, K Sletten, P. Westermark Oslo , Norway and Dordrecht , The Netherlands , Kluwer Academic Publishers, 1990, pp. 7–14. Google Scholar 5 Benditt EP, Erikson N, Hermodson MA, Ericsson LH: The major proteins of human and monkey amyloid substance: Common properties including unusual N-terminal amino acid sequence. FEBS Lett 19: 169–173, 1971. 10.1016/0014-5793(71)80506-9 CASPubMedWeb of Science®Google Scholar 6 Levin M, Pras M, Franklin EC: Immunologic studies of the major nonimmunoglobulin protein of amyloid: Identification and partial characteristic of a related serum component. J Exp Med 138: 373–380, 1973. 10.1084/jem.138.2.373 CASPubMedWeb of Science®Google Scholar 7 Costa PP, Figueira AS, Bravo FR: Amyloid fibril protein related to prealbumin in familial amyloid polyneuropathy. Proc Natl Acad Sci USA 75: 4499–4503, 1978. 10.1073/pnas.75.9.4499 CASPubMedWeb of Science®Google Scholar 8 Nichols WC, Dwulet FE, Leipnieks J, Benson MD: Variant apolipoprotein A1 as a major constituent of a human hereditary amyloid. Biochem Biophys Res Commun 156: 762–768, 1988. 10.1016/S0006-291X(88)80909-4 CASPubMedWeb of Science®Google Scholar 9 Maury CPJ, Alli K, Baumann M: Finnish hereditary amyloidosis. Amino acid sequence homology between the amyloid fibril protein and human plasma gelsolin. FEBS Lett 260: 85–87, 1988. 10.1016/0014-5793(90)80072-Q CASWeb of Science®Google Scholar 10 Gejyo F, Yamada T, Odani S, Nakagawa Y, Arakawa M, Kunitomo T, Katoaka H, Suzuki M, Hirasawa Y, Shirahama T, Cohen AS, Schmid K: A new form of amyloid protein associated with chronic hemodialysis was identified as β2-microglobulin. Biochem Biophys Res Commun 129: 701–706, 1985. 10.1016/0006-291X(85)91948-5 CASPubMedWeb of Science®Google Scholar 11 Shirahama T, Skinner M, Cohen AS, Gejyo F, Arakawa M, Suzuki M, Hirasawa Y: Histochemical and immunohistochemical characterization of amyloid associated with chronic hemodialysis as β2-microglobulin. Lab Invest 53: 705–709, 1985. CASPubMedWeb of Science®Google Scholar 12 Shirahama T, Miura K, Ju ST, Kisilevsky R, Gruys E, Cohen AS: Amyloid enhancing factor-loaded macrophages in amyloid fibril formation. Lab Invest 62: 61–68, 1990. CASPubMedWeb of Science®Google Scholar 13 Glenner GG: Amyloid deposits and amyloidosis. The β-fibrillosis. N Engl J Med 302: 1283–1287, 1980. 10.1056/NEJM198006053022305 CASPubMedWeb of Science®Google Scholar 14 Pepys MB, Baltz ML, De Beer FC. Biology of serum amyloid P component. Ann NY Acad Sci 389: 286–297, 1982. 10.1111/j.1749-6632.1982.tb22144.x CASPubMedWeb of Science®Google Scholar 15 Muñoz-Gomez J, Bergada-Barado E, Gomez-Perez R, Llopart-Buisan E, Subias-Sobrevia E, Rotés-Querol J, Solé-Arqués M: Amyloid arthropathy in patients undergoing periodical hemodialysis for chronic renal failure: A new complication. Ann Rheum Dis 44: 729–733, 1985. 10.1136/ard.44.11.729 CASPubMedWeb of Science®Google Scholar 16 Bardin T, Kuntz D, Zingraff J, Voisin MC, Zelmar A, Lansaman J: Synovial amyloidosis in patients undergoing long-term hemodialysis. Arthritis Rheum 28: 1052–1058, 1985. 10.1002/art.1780280913 PubMedWeb of Science®Google Scholar 17 Drüeke TB, Zingraff J, Nöel LH, Bardin T, Kuntz D: Amyloidosis and dialysis: Pathophysiological aspects. Contrib Nephrol 62: 60–66, 1988. 10.1159/000415476 CASPubMedGoogle Scholar 18 Kleinman KS, Coburn JW: Amyloid syndrome associated with hemodialysis. Kidney Int 35: 567–575, 1989. 10.1038/ki.1989.25 CASPubMedWeb of Science®Google Scholar 19 Maury CPJ: β2-Microglobulin amyloidosis. A systemic amyloid disease affecting primarily synovium and bone in long-term dialysis patients. Rheumatol Int 10: 1–8, 1990. 10.1007/BF02274774 CASPubMedWeb of Science®Google Scholar 20 Campistol JM, Cases A, Torras A, Solé M, Muñoz-Gomez J, Montoliu J, Lopez-Pedret J, Revert LL: Visceral involvement of dialysis-amyloidosis. Am J Nephrol 7: 390–393, 1987. 10.1159/000167505 PubMedWeb of Science®Google Scholar 21 Morita T, Suzuki M, Kamimura A, Hirasawa Y: Amyloidosis of a possible new type in patients receiving long-term hemodialysis. Arch Pathol Lab Med 109: 1029–1032, 1985. PubMedWeb of Science®Google Scholar 22 Gorevic PD, Muñoz PC, Casey TT, DiRaimondo CR, Stone WJ, Prelli FC, Rodrigues MM: Polymerization of intact β2-microglobulin in tissue causes amyloidosis in patients on chronic hemodialysis. Proc Natl Acad Sci USA 83: 1908–7912, 1986. 10.1073/pnas.83.20.7908 CASWeb of Science®Google Scholar 23 Warren DJ, Otieno LS: Carpal tunnel syndrome in patients on intermittent haemodialysis. Postgrad Med J 51: 450–452, 1975. 10.1136/pgmj.51.597.450 CASPubMedWeb of Science®Google Scholar 24 Assenat H, Calemard E, Charra B, Laurent G, Terrat JC, Vanel T: Hemodialyse. Syndrome du canal carpien et substance amyloide. Nouv Press Med 24: 1715, 1980. Google Scholar 25 Charra B, Calemard E, Uzan M, Terrat JC, Vanel T, Laurent G: Carpal tunnel syndrome, shoulder pain and amyloid deposits in long-term haemodialysis patients. Proc Eur Dial Transplant Assoc-ERA 21: 291–295, 1984. Web of Science®Google Scholar 26 Brancaccio D, Gallieni M, Padovese P, Anelli A, Coggi G, Uslenghi C: Dialysis amyloidosis with massive popliteal deposition of β2-microglobulin amyloid. Lancet 2: 802, 1988. 10.1016/S0140-6736(88)92459-2 CASPubMedWeb of Science®Google Scholar 27 Linke RP, Bommer J, Ritz E, Waldherr R, Eulitz M: Amyloid kidney stones of uremic patients consist of β2-microglobulin fragments. Biochem Biophys Res Commun 136: 665–671, 1986. 10.1016/0006-291X(86)90492-4 CASPubMedWeb of Science®Google Scholar 28 Bardin T, Zingraff J, Shirahama T, Nöel LH, Voisin MC, Drüeke T, Skinner M, Cohen AS, Kuntz D: Hemodialysis-associated amyloidosis and β2-microglobulin. Clinical and immunohistochemical study. Am J Med 83: 419–424, 1987. 10.1016/0002-9343(87)90750-9 CASPubMedWeb of Science®Google Scholar 29 Casey TT, Stone WJ, Di Raimondo CR, Brantley BD, Di Raimondo CHV, Gorevic PD, Page DL. Tumoral amyloidosis of bone of β2-microglobulin origin in association with long-term hemodialysis: A new type of amyloid disease. Hum Pathol 17: 731–738, 1986. 10.1016/S0046-8177(86)80183-6 PubMedWeb of Science®Google Scholar 30 Solé M, Cardesa A, Palacin A, Muñoz-Gomez J, Campistol JM: Morphological and immunohistochemical findings in dialysis-related amyloidosis. Appl Pathol 7: 350–360, 1989. CASPubMedGoogle Scholar 31 Hauglustaine D, Waer M, Michielsen P, Goebels J, Vandeputte M: Haemodialysis membranes, serum β2-microglobulin, and dialysis amyloidosis. Lancet 1: 1211, 1986. 10.1016/S0140-6736(86)91189-X CASPubMedWeb of Science®Google Scholar 32 Floege J, Granolleras C, Koch KM, Shaldon S: Which membrane? Should β2-microglobulin decide on the choice of today's hemodialysis membrane Nephron 50: 177–181, 1988. 10.1159/000185153 CASPubMedWeb of Science®Google Scholar 33 Argiles A, Mouradi G, Axelrud-Cavadore C, Watrin A, Mion C, Cavadore J: High-molecular mass proteins in haemodialysis-associated amyloidosis. Clin Sci 76: 547–552, 1989. 10.1042/cs0760547 CASPubMedWeb of Science®Google Scholar 34 Blumberg A, Burgi W: Behavior of β2-microglobulin in patients with chronic renal failure undergoing hemodialysis, hemodiafiltration and continuous ambulatory peritoneal dialysis (CAPD). Clin Nephrol 27: 245–249, 1987. CASPubMedWeb of Science®Google Scholar 35 Zingraff JJ, Noel LH, Bardin T, Atienza C, Zins B, Drueke TB, Kuntz D: β2-Microglobulin amyloidosis in chronic renal failure. N Engl J Med 323: 1070–1071, 1990. 10.1056/NEJM199010113231514 CASPubMedWeb of Science®Google Scholar 36 Van Ypersele de Strihou C, Honhon B, Vandenbroucke JM, Huaux JP, Nöel H, Maldague B. Dialysis amyloidosis. Adv Nephrol 17: 401–422, 1988. PubMedGoogle Scholar 37 Varga J, Fenves A: Haemodialysis-associated amyloidosis: Differences in frequency between Europe and USA. Lancet 2: 224, 1987. 10.1016/S0140-6736(87)90815-4 PubMedWeb of Science®Google Scholar 38 Van Ypersele de Strihou C, Jadoul M, Malgem J, Maldague B, Jamart J: The Working Party on Dialysis Amyloidosis: Effect of dialysis membrane and patient's age on signs of dialysis related amyloidosis. Kidney Int 39: 1012–1019, 1991. 10.1038/ki.1991.128 PubMedWeb of Science®Google Scholar 39 Fuchs A, Jagirdar J, Schwartz IS: β2-Microglobulin amyloidosis (AB2M) in patients undergoing long-term hemodialysis. A new type of amyloid. Clin Nephrol 88: 302–306, 1989. Web of Science®Google Scholar 40 Gauchier A, Kessler M, Azoulay E, Netter P, Pere P: Arthropathie du dialyse role preponderant de l'âge. Résultat d'une étude réalisée dans 17 centres de dialyse chez 140 malades hémodialysés depuis plus de 10 ans. Rev Rhum Mal Osteoartic 56: 123–125, 1989. PubMedWeb of Science®Google Scholar 41 Sethi D, Naunton TC, Brown EA, Cary NRB, Erhardt CC, Pazianas M, Maini RN, Woodrow DF, Gower PE: Dialysis arthropathy: A clinical, biochemical, radiological and histological study of 36 patients. Q J Med 282: 1061–1082, 1990. 10.1093/qjmed/77.1.1061 Google Scholar 42 Brown EA, Arnold IR, Gower PE: Dialysis arthropathy: Complication of long term treatment with haemodialysis. Br Med J 292: 163–166, 1986. 10.1136/bmj.292.6514.163 CASPubMedWeb of Science®Google Scholar 43 Fischbach M, Hamel G, Koehl C, Geisert J: β2-Microglobulin in hemodialyzed children: Long-term efficiency follow-up. Nephron 53: 110–114, 1989. 10.1159/000185721 CASPubMedWeb of Science®Google Scholar 44 Bergada E, Montoliu J, Subias R, Solé M, Lopez-Pedret J, Revert L: Síndrome del tunel carpiano con depósito local y articular de sustancia amiloide en el hemodializado. Med Clin (Barc) 86: 319–322, 1986. CASPubMedWeb of Science®Google Scholar 45 Gejyo F, Homma N, Saito H, Arakawa M: Carpal tunnel syndrome and β2-microglobulin amyloidosis: Histological and biochemical aspects, in Dialysis Amyloidosis, edited by F Gejyo, D Brancaccio, T. Bardin Milan , Wichtig Editore, 1989, pp. 35–42. Google Scholar 46 Muñoz-Gomez J, Estrada P: Early radiologic manifestations of destructive spondyloarthropathy in hemodialyzed patients. Arthritis Rheum 28: 1075–1076, 1987. Google Scholar 47 Kuntz D, Naveau B, Bardin T, Drüeke T, Treves R, Dryll A: Destructive spondyloarthropathies in hemodialyzed patients. A new syndrome Arthritis Rheum 27: 369–375, 1984. 10.1002/art.1780270402 PubMedWeb of Science®Google Scholar 48 Maruyama H, Gejyo F, Arakawa M: A magnetic resonance imaging study of destructive spondyloarthropathy in long-term hemodialysis patients. Nephron 59: 71–74, 1991. 10.1159/000186521 CASPubMedWeb of Science®Google Scholar 49 Kuntz D, Bardin T: Dialysis destructive arthropathies, in Dialysis Amyloidosis, edited by F Gejyo, D Brancaccio, T. Bardin Milan , Wichtig Editore, 1989, pp. 101–110. Google Scholar 50 Muñoz-Gomez J, Solé M: Dialysis arthropathy of amyloid origin. J Rheumatol 17: 5–7, 1990. PubMedWeb of Science®Google Scholar 51 DiRaimondo CR, Casey TT, Di Raimondo CHV, Stone WJ: Pathological fractures associated with idiopathic amyloidosis of bone in chronic hemodialysis patients. Nephron 43: 22–27, 1986. 10.1159/000183712 PubMedWeb of Science®Google Scholar 52 Campistol JM, Solé M, Muñoz-Gomez J, Riba J, Ramón R, Revert LL: Pathological fractures in patients with amyloidosis associated with hemodialysis. J Bone Joint Surg [Am] 72: 568–573, 1990. 10.2106/00004623-199072040-00015 CASPubMedWeb of Science®Google Scholar 53 Campistol JM, Solé M, Muñoz-Gomez J, Lopez-Pedret J, Revert L: Systemic involvement of dialysis-amyloidosis. Am J Nephrol 10: 389–396, 1990. 10.1159/000168154 CASPubMedWeb of Science®Google Scholar 54 Shinoda T, Komatsu M, Aizawa T, Shirota T, Yamada T, Ehara T, Mizukami E: Intestinal pseudo-obstruction due to dialysis amyloidosis. Clin Nephrol 32: 284–289, 1989. CASPubMedWeb of Science®Google Scholar 55 Nöel LH, Zingraff J, Bardin T, Atienza C, Kuntz D, Drüeke T: Tissue distribution of dialysis amyloidosis. Clin Nephrol 27: 175–178, 1987. CASPubMedWeb of Science®Google Scholar 56 Naidich JB, Karmel MI, Mossey RT, Bluestone P, Stein HL: Osteoarthropathy of the hand and wrist in patients undergoing long-term hemodialysis. Radiology 164: 205–209, 1987. 10.1148/radiology.164.1.3588905 CASPubMedWeb of Science®Google Scholar 57a Solé M, Muñoz-Gomez J, Campistol JM: Role of amyloid in dialysis-related arthropathies. A morphological analysis of 23 cases. Virchows Arch [A] 417: 523–528, 1990. 10.1007/BF01625733 CASPubMedWeb of Science®Google Scholar 57b Solé M, Campistol JM, Muñoz-Gomez J: Abdominal fat aspirate biopsy in dialysis-related amyloidosis. Arch Intern Med 148: 988, 1989. 10.1001/archinte.148.4.988 PubMedGoogle Scholar 58 Muñoz-Gomez J, Gomez-Perez R, Solé-Arqués M, Llopart-Buisan E: Synovial fluid examination for the diagnosis of synovial amyloidosis in patients with chronic renal failure undergoing haemodialysis. Ann Rheum Dis 46: 324–326, 1987. 10.1136/ard.46.4.324 CASPubMedWeb of Science®Google Scholar 59 Gejyo F, Odani S, Yamada T, Honma N, Saito H, Suzuki Y, Nakagawa Y, Kobayashi H, Marumaya Y, Hirasawa Y, Suzuki M, Arakawa M: β2-Microglobulin: A new form of amyloid protein associated with chronic hemodialysis. Kidney Int 30: 385–390, 1986. 10.1038/ki.1986.196 CASPubMedWeb of Science®Google Scholar 60 Nelson SR, Hawkins PN, Richardson S, Lavender JP, Sethi D, Gower PE, Pugh CW, Winearls CG, Oliver DO, Pepys MB: Imaging of hemodialysis-associated amyloidosis with 123I-serum amyloid P component. Lancet 2: 335–339, 1991. 10.1016/0140-6736(91)90478-8 CASWeb of Science®Google Scholar 61 Floege J, Burchert W, Brandis A, Gielow P, Nonnast-Daniel B, Spindler E, Hundershagen H, Shaldon S, Koch KM: Imaging of dialysis-related (AB amyloid) amyloid deposits with 131I-β2-microglobulin. Kidney Int 38: 1169–1176, 1990. 10.1038/ki.1990.329 CASPubMedWeb of Science®Google Scholar 62 Baldrati L, Balbi B, Rocchi, Bonsanto R, Docci D, Capponcini C, Feletti C, Mughetti M: Diagnostic imaging for the study of popliteal masses in dialyzed patients. Radiol Med (Torino) 81: 234–237, 1991. CASPubMedGoogle Scholar 63 Kokubo T, Takatori Y, Okutsu I, Takemura T, Itai Y: MR demonstration of intraosseous β2-microglobulin amyloidosis. J Comput Assist Tomogr 14: 1030–1032, 1990. 10.1097/00004728-199011000-00038 CASPubMedWeb of Science®Google Scholar 64 Kay J, Benson CB, Lester S, Corson JM, Pinkus GS, Lazarus JM, Owen WF: Utility of high resolution ultrasound for the diagnosis of dialysis-related amyloidosis. Arthritis Rheum 35: 926–932, 1992. 10.1002/art.1780350812 CASPubMedWeb of Science®Google Scholar 65 Cunningham BA, Wang JL, Berggar I, Peterson PA: The complete amino acid sequence of β2-microglobulin. Biochemistry 12: 4811–4822, 1973. 10.1021/bi00748a001 CASPubMedWeb of Science®Google Scholar 66 Gorevic PD, Muñoz P: Dialysis amyloidosis: β2-Microglobulin in the context of other amyloidogenic proteins. Blood Purif 6: 132–144, 1988. 10.1159/000169495 CASPubMedWeb of Science®Google Scholar 67 Peterson PA: β2-microglobulin on the cell surface. Med Biol 55: 74–81, 1977. CASPubMedWeb of Science®Google Scholar 68 Zingraff J, Drueke T: Can the nephrologist prevent dialysis-related amyloidosis Am J Kidney Dis 18: 1–11, 1991. 10.1016/S0272-6386(12)80283-6 CASPubMedWeb of Science®Google Scholar 69 Shishido K, Akizawa T, Sato M, Koshikawa S: Estimation of β2-microglobulin production from lymphocytes in hemodialysis patients. Nephron 51: 132–133, 1989. 10.1159/000185273 CASPubMedWeb of Science®Google Scholar 70 Vincent C, Revillard JP, Galland M, Traeger J: Serum β2-microglobulin in hemodialyzed patients. Nephron 21: 260–268, 1978. 10.1159/000181402 PubMedWeb of Science®Google Scholar 71 Revillard JP, Vincent C: Structure and metabolism of β2-microglobulin. Contrib Nephrol 62: 44–53, 1988. 10.1159/000415474 CASPubMedGoogle Scholar 72 Stone WJ, Hakim RM: β2-Microglobulin amyloidosis in long-term dialysis patients. Am J Nephrol 9: 177–183, 1989. 10.1159/000167962 CASPubMedWeb of Science®Google Scholar 73 Argiles A, Mourad G, Berta P, Polito C, Canaud B, Robinet-Levy M, Mion C: Dialysis-associated amyloidosis in a patient on long-term post-dilutional hemofiltration. Nephron 46: 96–97, 1987. 10.1159/000184316 CASPubMedWeb of Science®Google Scholar 74 De Broe ME, Nouwen J, Waeleghem JP: On the mechanism and site of production of β2-microglobulin during haemodialysis. Nephrol Dial Transplant 2: 124–126, 1987. PubMedGoogle Scholar 75 De Broe ME: Clinical significance of bio-incompatibility in haemodialysis. Contrib Nephrol 62: 35–43, 1988. 10.1159/000415473 PubMedGoogle Scholar 76 Campistol JM, Molina R, Rodriguez R, Munoz-Gomez J, Revert Ll: Dialysis membranes inhibit synthesis and release of β2-microglobulin in lymphocyte culture. Nephron 59: 691–692, 1991. 10.1159/000186681 CASPubMedWeb of Science®Google Scholar 77 Paczek L, Schaefer RM, Heidland A: Dialysis membranes inhibit in vitro release of β2-microglobulin from human lymphocytes. Nephron 56: 267–270, 1990. 10.1159/000186152 CASPubMedWeb of Science®Google Scholar 78 Jahn B, Betz M, Deppish R, Janssen O, Hänsch GM, Ritz E: Stimulation of β2-microglobulin synthesis in lymphocytes after exposure to cuprophane dialyzer membranes. Kidney Int 40: 285–290, 1991. 10.1038/ki.1991.212 CASPubMedWeb of Science®Google Scholar 79 Dinarello CHA, Koch KM, Shaldon S: Interleukin-1 and its relevance in patients treated with hemodialysis. Kidney Int 33: 21–26, 1988. Google Scholar 80 Dinarello CHA, Cannon JG, Wolff SHM, Bernheim HA, Beutler B, Cerami A, Figari IS, Palladino MA, O'Connor JV: Tumor necrosis factor (Cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med 163: 1433–1450, 1986. 10.1084/jem.163.6.1433 CASPubMedWeb of Science®Google Scholar 81 Tielmans C, Dratwa M, Bergmann P, Goldman M, Flamion B, Collart F, Wens R: Continuous ambulatory peritoneal dialysis, protective against developing dialysis-associated amyloid Nephron 53: 174–175, 1989. 10.1159/000185737 PubMedWeb of Science®Google Scholar 82 Cornellis F, Bardin T, Zingraff J, Drüeke T: β2-Microglobulin amyloidosis and peritoneal dialysis, in Dialysis Amyloidosis, edited by F Gejyo, D Brancaccio, T. Bardin Milan , Wichtig Editore, 1989, pp. 119–122. Google Scholar 83 Becker JW, Reeke GN. Three-dimensional structures of β2-microglobulin. Proc Natl Acad Sci USA 82: 4225–4229, 1985. 10.1073/pnas.82.12.4225 CASPubMedWeb of Science®Google Scholar 84 Berggard B, Bjorck L, Cigen R, Logdberg L: β2-Microglobulin. Scand J Clin Lab Invest 40: 13–25, 1980. Web of Science®Google Scholar 85 D'Urso CM, Wang Z, Cao Y, Tatake R, Zeff RA, Ferrone S: Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in β2-M gene expression. J Clin Invest 87: 284–292, 1991. 10.1172/JCI114984 CASPubMedWeb of Science®Google Scholar 86 Linke RP, Hampl H, Lobeck H, Ritz E, Bommer J, Waldherr R, Eulitz M: Lysine-specific cleavage of β2-microglobulin in amyloid deposits associated with hemodialysis. Kidney Int 36: 675–681, 1989. 10.1038/ki.1989.245 CASPubMedWeb of Science®Google Scholar 87 Connors LH, Shirahama T, Sipe JD, Skinner M, Fenves A, Cohen AS: Formation of amyloid fibrils from intact β2-microglobulin. Biochem Biophys Res Commun 131: 1063–1068, 1985. 10.1016/0006-291X(85)90198-6 CASPubMedWeb of Science®Google Scholar 88 Campistol JM, Solé M, Bombi JA, Rodriguez R, Mirapeix E, Muñoz-Gomez J, Revert Ll: In vitro spontaneous synthesis of β2-microglobulin amyloid fibrils. Am J Pathol 141: 241–248, 1992. CASPubMedWeb of Science®Google Scholar 89 Ogawa H, Saito A, Hirabayashi N, Hara K: Amyloid deposition in systemic organs in long-term hemodialysis patients. Clin Nephrol 28: 199–204, 1987. PubMedWeb of Science®Google Scholar 90 Odani H, Oyama R, Titani K, Ogawa H, Saito A: Purification and complete amino acid sequence of novel β2-microglobulin. Biochem Biophys Res Commun 168: 1223–1226, 1990. 10.1016/0006-291X(90)91159-P CASPubMedWeb of Science®Google Scholar 91 Homma N, Gejyo F, Isemura M, Arakawa M: Collagen-binding affinity of β2-microglobulin, a preprotein of hemodialysis-associated amyloidosis. Nephron 53: 37–40, 1989. 10.1159/000185699 CASPubMedWeb of Science®Google Scholar 92 Peterson J, Kang MS, Li CC: Effect of β2-microglobulin on bone resorption in mice (Abstract). Kidney Int 37: 304, 1990. Google Scholar 93 Canalis E, McCarthy T, Centrella M: Growth factors and the regulation of bone remodeling. J Clin Invest 81: 277–281, 1988. 10.1172/JCI113318 CASPubMedWeb of Science®Google Scholar 94 Huffer WE: Morphology and biochemistry of bone remodeling: Possible control by vitamin D, parathyroid hormone, and other substances. Lab Invest 59: 418–442, 1988. CASPubMedWeb of Science®Google Scholar 95 Vaes G: Cellular biology and biochemical mechanism of bone resorption. Clin Orthop 231: 239–271, 1988. 10.1097/00003086-198806000-00033 CASPubMedWeb of Science®Google Scholar 96 Brinckerhoff CE, Mitchell TI: Autocrine control of collagenase synthesis. J Cell Physiol 136: 72–80, 1988. 10.1002/jcp.1041360109 CASPubMedWeb of Science®Google Scholar 97 Brinckerhoff CE, Mitchell TI, Karmilowicz MJ, Kluve-Beckerman B, Benson MD: Autocrine induction of collagenase by serum amyloid A-like and β2-microglobulin-like proteins. Science 243: 655–667, 1989. 10.1126/science.2536953 CASPubMedWeb of Science®Google Scholar 98 Campistol JM, Shirahama TS, Abraham C, Orfile R, Solé M, Cohen AS, Skinner M: Immunohistochemical and biochemical identification of plasma proteinase inhibitors in dialysis-amyloidosis. Kidney Int 42: 915–923, 1992. 10.1038/ki.1992.368 CASPubMedWeb of Science®Google Scholar 99 Drukker W: Haemodialysis: A historical view, in Replacement of Renal Function by Dialysis, edited by W Drukker, FM Parsons, JF Maher. Dordrecht , Martinus Nijhoff, 1983, pp. 3–52. 10.1007/978-94-009-6768-7_2 Google Scholar 100 Chan YL, Furlong TJ, Cornish CJ, Posen S: Dialysis osteodystrophy. A study involving 94 patients. Medicine (Baltimore) 64: 296–309, 1985. 10.1097/00005792-198509000-00002 CASPubMedWeb of Science®Google Scholar 101 Ureña P, Nguyen AT, Jehenne G, Descamps-Latscha B, Drueke T, Basile C: Short-term administration of colchicine to haemodialysis patients: Plasma β2-microglobulin and phagocyte oxidative response. Nephron 55: 348–349, 1990. 10.1159/000185995 PubMedWeb of Science®Google Scholar 102 Ponz E, Campistol JM, Muñoz-Gomez J, Oppenheimer F, Vilardell J, Andreu J: Renal transplantation for dialysis-amyloidosis. Transplant Proc 24: 118–119, 1992. PubMedWeb of Science®Google Scholar 103 Okutsu I, Ninomiya S, Takatori Y, et al.: Endoscopic management of shoulder pain in long-term hemodialysis patients. Nephrol Dial Transplant 6: 117–119, 1990. 10.1093/ndt/6.2.117 Web of Science®Google Scholar 104 Campistol JM, Muñoz-Gomez J, Oppenheimer F, Ricart MJ, Vilardell J, Andreu J: Renal transplantation for dialysis arthropathy. Lancet 2: 900, 1988. 10.1016/S0140-6736(88)92490-7 CASPubMedWeb of Science®Google Scholar 105 Sethi D, Brown EA, Maini RN, Gower PE: Renal transplantation for dialysis arthropathy. Lancet 1: 448–449, 1988. 10.1016/S0140-6736(88)90434-5 PubMedGoogle Scholar 106 Jadoul M, Malghem J, Pirson Y, Maldague B, Ypersele C: Effect of renal transplantation on the radiological signs of dialysis amyloid osteoarthropathy. Clin Nephrol 32: 194–197, 1989. PubMedWeb of Science®Google Scholar Citing Literature Volume6, Issue2March 1993Pages 117-126 ReferencesRelatedInformation
Referência(s)